Results 1 to 10 of about 18,145 (196)
Some of the next articles are maybe not open access.
Drugs, 2007
Ranibizumab is the antigen-binding fragment of a recombinant, humanised monoclonal antibody, which binds with high affinity to, and inhibits the activity of, all active forms of vascular endothelial growth factor A, an important mediator in the development of choroidal neovascularisation.
Stephanie K A, Blick +2 more
+7 more sources
Ranibizumab is the antigen-binding fragment of a recombinant, humanised monoclonal antibody, which binds with high affinity to, and inhibits the activity of, all active forms of vascular endothelial growth factor A, an important mediator in the development of choroidal neovascularisation.
Stephanie K A, Blick +2 more
+7 more sources
In-vitro characterization of ranibizumab release from the Port Delivery System
Journal of Controlled Release, 2022Katie Maass +2 more
exaly